- Government Regulation Pharmaceutical Pricing and Reimbursement for further details. In many countries outside the U.S., government-sponsored healthcare systems are the primary payors for drugs. With increasing budgetary constraints and differing views on or challenges in valuing medicines, governments and payors in many countries are applying a variety of measures to exert downward price pressure. These measures can include mandatory price controls, price referencing, therapeutic-reference pri...
Q2 FY2026 — expected 2026-07-28
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-02 | 2025-12-31 | 0001193125-26-085818 | EDGAR | 102K words |
| 2025-03-12 | 2024-12-31 | 0000950170-25-037620 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0000950170-24-022636 | EDGAR | — |
| 2023-03-01 | 2022-12-31 | 0000950170-23-005336 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0000950170-22-002401 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001564590-21-008382 | EDGAR | — |
| 2020-02-25 | 2019-12-31 | 0001564590-20-006390 | EDGAR | — |
| 2019-02-27 | 2018-12-31 | 0001564590-19-004655 | EDGAR | — |
| 2018-02-27 | 2017-12-31 | 0001564590-18-003389 | EDGAR | — |
| 2017-03-01 | 2016-12-31 | 0001193125-17-065969 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-29 | 2025-09-30 | 0001193125-25-254621 | EDGAR | 32K words |
| 2025-07-30 | 2025-06-30 | 0000950170-25-099879 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0000950170-25-064981 | EDGAR | — |
| 2024-10-30 | 2024-09-30 | 0000950170-24-118990 | EDGAR | — |
| 2024-07-31 | 2024-06-30 | 0000950170-24-088233 | EDGAR | — |
| 2024-05-01 | 2024-03-31 | 0000950170-24-050886 | EDGAR | — |
| 2023-11-01 | 2023-09-30 | 0000950170-23-057120 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0000950170-23-036771 | EDGAR | — |
| 2023-05-03 | 2023-03-31 | 0000950170-23-016877 | EDGAR | — |
| 2022-10-27 | 2022-09-30 | 0000950170-22-020246 | EDGAR | — |
| 2022-08-03 | 2022-06-30 | 0000950170-22-014008 | EDGAR | — |
| 2022-05-04 | 2022-03-31 | 0000950170-22-007188 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-27 | 0001193125-26-129334 | EDGAR | 1K words |
| 2026-02-25 | 0001193125-26-068511 | EDGAR | — |
| 2026-01-08 | 0001193125-26-006992 | EDGAR | — |
| 2025-10-29 | 0001193125-25-254620 | EDGAR | — |
| 2025-10-22 | 0001193125-25-246973 | EDGAR | — |
| 2025-07-30 | 0000950170-25-099878 | EDGAR | — |
| 2025-06-24 | 0000950170-25-089218 | EDGAR | — |
| 2025-05-15 | 0000950170-25-072817 | EDGAR | — |
| 2025-05-07 | 0000950170-25-064980 | EDGAR | — |
| 2025-04-29 | 0000950170-25-060165 | EDGAR | — |
308 total filings indexed. 276 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000897448 |
| Ticker | AMRN |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | X0 |
| Website | https://www.amarincorp.com |
| Listed | 1993-04-01 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report